JNJ-54175446 is a research compound being investigated in clinical trials as a brain-permeable P2X7 antagonist. It is studied for its effects on amyloid biomarkers and cytokine profiles in the cerebrospinal fluid and plasma of healthy participants.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Caspofungin
pharmaceutical raw material
Sofpironium bromide
pharmaceutical raw material
BPC-157 acetate
pharmaceutical raw material
Vimseltinib
pharmaceutical raw material
[2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone
CWFVVQFVGMFTBD-SECBINFHSA-N
C[C@@H]1C2=C(CCN1C(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl)N(N=N2)C4=NC=C(C=N4)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.